Amid the changing technological landscape, investors are beginning to wonder which companies are poised to revolutionize the market further. The answer may very well be a group of companies known as ...
KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...
Preparing for UPSC Prelims? Important Science & Technology topics include ISRO missions, biotechnology, defence tech, AI, quantum computing, renewable energy.
INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
Cytotrait is developing crop engineering technology for precise gene editing in plant organelles to enable crops with ...
The multiverse offers many unique and compelling variants of the Fantastic Four, and these are the best of the best.
Stephen Hawking's black hole fame wasn't his only focus — he also laid out multiple existential threats. Here are five doomsday risks he talked about.
FOR decades, African scientists have contributed essential data to global scientific research. Increasingly, however, they are no longer just contributors. Across the continent, researchers are ...
Brains are staggeringly complex. Usually, when we talk about shifting neurodevelopmental traits, we’re looking at years of intensive therapy and complex interventions. But new research from Stanford ...
Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...
Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results